CLINICAL AND EPIDEMIOLOGICAL PREDICTORS OF MORTALITY AFTER LIVER TRANSPLANTATION
Mamatkulov T. T. & Kallieva T. A.
Annotatsiya
Liver transplantation is the most effective treatment for end-stage liver disease; however, postoperative survival is influenced by multiple donor- and recipient-related factors. In Central Asia, including Uzbekistan, the growing burden of chronic liver diseases such as viral hepatitis, non-alcoholic fatty liver disease, and metabolic syndrome, combined with limited transplant resources, makes outcome optimization a critical clinical and public health issue. A retrospective multicenter study was conducted involving 250 liver transplant recipients treated in major transplantation centers in Uzbekistan. Data on recipient characteristics (age, sex, BMI, MELD score, renal function, infectious complications), donor characteristics (age and BMI), and postoperative outcomes were analyzed. Statistical methods included chi-square tests, t-tests, ROC curve analysis, and multivariate logistic regression. Propensity score weighting was applied to reduce potential confounding bias. Statistical significance was set at p < 0.05. Among 250 patients, mortality varied significantly across follow-up periods (p = 0.010). Higher MELD scores, increased donor age, elevated recipient BMI, and renal impairment were significantly associated with increased risk of mortality (p < 0.05). Infectious complications showed a significant association in univariate analysis but were not consistently significant in multivariate models. ROC analysis demonstrated moderate predictive ability of MELD score and donor age for post-transplant mortality. Multivariate logistic regression identified MELD score, donor age, recipient BMI, and renal dysfunction as independent predictors of survival outcomes. Post-liver transplantation mortality in Uzbekistan is influenced by a combination of clinical and donor-related factors. MELD score, donor age, renal dysfunction, and recipient BMI represent key predictors of survival. Strengthening pre-transplant risk stratification and improving perioperative management may enhance transplantation outcomes in Central Asia.
Adabiyotlar
- Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470.
- Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transplantation. 2002;8(9):851–858.
- Saab S, Jimenez M, Greenberg MS, et al. Impact of MELD on liver transplant outcomes: a systematic review. Liver International. 2006;26(3):347–356.
- Salvalaggio PR, Dzebisashvili N, MacLeod KE, et al. The interaction among donor characteristics, severity of liver disease, and outcome of liver transplantation. Liver Transplantation. 2007;13(2):279–287.
- Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. American Journal of Transplantation. 2006;6(4):783–790.
- Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 1-year mortality after liver transplantation: influence of donor and recipient factors. New England Journal of Medicine. 2006;355(14):1331–1340.
- de Grauwe A, et al. Renal dysfunction and outcomes after liver transplantation: a review. Transplantation Reviews. 2014;28(4):190–196.
- Saab S, Yeganeh M, Nguyen N, et al. Body mass index and liver transplantation outcomes. Clinical Transplantation. 2009;23(1):1–8.
- European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines: Liver transplantation. Journal of Hepatology. 2016;64(2):433–485.